The Leading CRO in Eastern Europe

Since 2005, we have conducted hundreds of clinical trials in Russia and all of Eastern Europe. Our full range of CRO services has helped sponsors worldwide in offshoring their clinical trials and bringing their innovative treatments to market.

Thorough local expertise

• 14+ years’ experience facilitating clinical trials in Russia and Europe
• Risk-management approach
• 300+ clinical studies in portfolio
• Team of 200+ clinical operations professionals

Global sponsors

• Extensive project portfolio with sponsors from EU, US, CIS and Asia
• Successfully passed more than 60 audits by sponsors with no significant findings

Record-setting patient enrollment

• Access to the network of 1600+ leading scientific sites
• Extensive experience in fast enrollment of patients with different indications
• Patient engagement solutions
• CRO site management services

Quality

• FDA/EMA acceptable data
• Compliance with the international standards (ICH GCP), local regulatory requirements and internal SOPs

News

all news

25

Nov

OCT Clinical Completes Enrollment for Phase III Influenza Study

OCT Clinical Trials, a leading European CRO headquartered in Russia, today announced it has completed enrollment for a phase III study on behalf of Indian pharmaceutical company Dr. Reddy’s Laboratories.

read

LAST PATIENT IN: OCT CLINICAL REACHES THE ENROLLMENT TARGET IN TWO STUDIES IN HEMORRHOIDS

OCT team has successfully recruited the last patient for the phase III clinical trials in hemorrhoids. 312 female and male patients have been enrolled in both studies within 6 months.

read

20

Nov

11

Nov

Key takeaways from the 49th EMWA Conference

Last week, November 7th , the 49th EMWA Conference traditionally gathered industry experts from across the world, this time in Malmö, Sweden. In this release OCT Clinical’s delegation of medical writers share the key takeaways from the event.

read

Cereno Scientific, in collaboration with OCT Clinical, receives approval for the start of a Phase II clinical trial in Russia

Cereno Scientific AB announced, that the authorities in Russia have issued approval regarding the company’s application to initiate a Phase II clinical trial with the drug candidate CS1.

read

08

Oct

Meet us

all events

11-13

November 2019

BIO-Europe Hamburg

Hamburg, Germany

07-08

November 2019

2nd Meridian Clinical Trials

Boston, USA

06-07

November 2019

Life Sciences Summit

New York

11

Nov

BIO-Europe Hamburg

Schedule a meeting with our Business Development team Polina Shatrova pshatrova@oct-clinicaltrials.com

07

Nov

2nd Meridian Clinical Trials

Schedule a meeting with our Business Development team
Anna Yanaeva ayanaeva@oct-clinicaltrials.com

06

Nov

Life Sciences Summit

Schedule a meeting with our Business Development team
Anna Yanaeva ayanaeva@oct-clinicaltrials.com

Send a request